and from MF today.....I have only included CUV.
7 ASX All Ords shares elevated to 'strong buy' status in March......
The consensus analyst rating on Clinuvel Pharmaceuticals shares changed to strong buy on 15 March.The ASX All Ords share is currently changing hands for $15.21, up 5.9%. Morgans has an add rating and a $22 share price target on the stock.
and from MF today.....I have only included CUV.7 ASX All Ords...
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.59 |
Change
-0.150(1.02%) |
Mkt cap ! $730.6M | |||
| Open | High | Low | Value | Volume |
| $14.74 | $14.77 | $14.50 | $504.1K | 34.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 132 | $14.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.64 | 96 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |